CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-17 | Hively Brad Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +421,280 | 421,280 | ||
| 2022-12-16 | Miller Matthew P Chief Operating Officer | Purchase | +73,684 | $0.95 | $70K | 175,325 |
| 2022-12-07 | Virnich Daniel President | Option exercise | +175,000 | $0.86 | $151K | 448,585 |
| 2022-12-07 | Virnich Daniel President | Option exercise | +175,000 | $0.86 | $151K | 623,585 |
| 2022-12-07 | Virnich Daniel President | Option exercise · Non-Qualified Stock Option (right to buy) | −175,000 | 829,609 | ||
| 2022-12-07 | Virnich Daniel President | Option exercise · Non-Qualified Stock Option (right to buy) | −175,000 | 654,609 | ||
| 2022-11-17 | BARASCH RICHARD A Director | Grant or award | +65,174 | 207,193 | ||
| 2022-11-17 | Virnich Daniel President | Grant or award | +40,101 | 273,585 | ||
| 2022-11-17 | Virnich Daniel President | Grant or award · Non-Qualified Stock Option (right to buy) | +203,543 | 203,543 | ||
| 2022-11-17 | Simoneit Diona Chief Accounting Officer | Grant or award | +10,387 | 39,705 | ||
| 2022-11-17 | Simoneit Diona Chief Accounting Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +52,722 | 52,722 | ||
| 2022-11-17 | Shah Mihir Chief Financial Officer | Grant or award | +18,602 | 50,723 | ||
| 2022-11-17 | Shah Mihir Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +94,418 | 94,418 | ||
| 2022-11-17 | SARIN RAVI YANG Director | Grant or award | +22,708 | 45,899 | ||
| 2022-11-17 | Podnos Yale Chief Medical Officer | Grant or award | +14,164 | 57,247 | ||
| 2022-11-17 | Podnos Yale Chief Medical Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +71,895 | 71,895 | ||
| 2022-11-17 | Pacala Mark L Director | Grant or award | +2,160 | 52,780 | ||
| 2022-11-17 | Pacala Mark L Director | Grant or award | +29,057 | 81,837 | ||
| 2022-11-17 | O'Meara Maeve Director | Grant or award | +22,708 | 42,700 | ||
| 2022-11-17 | Miller Matthew P Chief Operating Officer | Grant or award | +23,607 | 101,641 |
Page 13 of 18 · 354 trades